Effect of switching recombinant human growth hormone: Comparative analysis of phase 3 clinical data
about
Switching to Omnitrope(®) from Other Recombinant Human Growth Hormone Therapies: A Retrospective Study in an Integrated Healthcare System.Ten years' clinical experience with biosimilar human growth hormone: a review of efficacy dataTen years of clinical experience with biosimilar human growth hormone: a review of safety dataSwitching From Originator to Biosimilar Human Growth Hormone Using Dialogue Teamwork: Single-Center Experience From Sweden.Interchangeability among reference insulin analogues and their biosimilars: regulatory framework, study design and clinical implications.Interchangeability of Biosimilars: A European Perspective.Assessing switchability for biosimilar products: modelling approaches applied to children's growth.To the Editor; A Commentary on "Switching From Originator to Biosimilar Human Growth Hormone Using a Dialogue Teamwork: Single-Center Experience From Sweden".Interchangeability of biosimilar and biological reference product: updated regulatory positions and pre- and post-marketing evidence.Biosimilarity and Interchangeability: Principles and Evidence: A Systematic Review.
P2860
Q34627035-01896424-5031-4910-A21B-0CD5F0CA6921Q36383939-562F9D52-9FA1-418A-82AD-75E34641BF3FQ36383943-6EE388EA-A691-419E-A871-0040AA26B4B6Q37414583-AF41F2A8-FAF4-47F2-8D26-4F5918B60FAEQ38812953-8BF937BD-2713-469E-AB36-E58CB3220567Q39000780-336E1B7F-C0DC-4AD5-9968-B411F4CC0910Q40924057-0A07D5B3-6EED-459A-93F9-BE0B65066D2FQ43054332-11446574-944A-4513-B938-CCAAD9BEA8DFQ48216426-0C56CBA2-DE1A-4B7C-9966-8CB417C4AB30Q49979586-5B1D11AC-4E72-4850-A33B-6D590C0B10CA
P2860
Effect of switching recombinant human growth hormone: Comparative analysis of phase 3 clinical data
description
2011 nî lūn-bûn
@nan
2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Effect of switching recombinan ...... lysis of phase 3 clinical data
@ast
Effect of switching recombinan ...... lysis of phase 3 clinical data
@en
type
label
Effect of switching recombinan ...... lysis of phase 3 clinical data
@ast
Effect of switching recombinan ...... lysis of phase 3 clinical data
@en
prefLabel
Effect of switching recombinan ...... lysis of phase 3 clinical data
@ast
Effect of switching recombinan ...... lysis of phase 3 clinical data
@en
P2093
P2860
P1433
P1476
Effect of switching recombinan ...... lysis of phase 3 clinical data
@en
P2093
Markus Zabransky
Mieczyslaw Szalecki
Mieczyslaw Walczak
Sigrid Balser
Tomasz Romer
P2860
P2888
P356
10.1007/S13554-011-0004-8
P577
2011-12-16T00:00:00Z
P5875
P6179
1043083190